Contributions to Hepatic Fibrosis in HIV-HCV Coinfected and HCV Monoinfected Patients

The aim of this study was to further explore the severity of liver disease and its predictors in a cohort of hepatitis C virus (HCV) infected patients, some of whom were coinfected with the human immunodeficiency virus (HIV). This is a retrospective, cross-sectional study of patients undergoing live...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of gastroenterology Vol. 101; no. 7; pp. 1509 - 1515
Main Authors MONTO, Alexander, KAKAR, Sanjay, DOVE, Lorna M, BOSTROM, Alan, MILLER, Erica L, WRIGHT, Teresa L
Format Journal Article
LanguageEnglish
Published Oxford Blackwell Publishing 01.07.2006
Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aim of this study was to further explore the severity of liver disease and its predictors in a cohort of hepatitis C virus (HCV) infected patients, some of whom were coinfected with the human immunodeficiency virus (HIV). This is a retrospective, cross-sectional study of patients undergoing liver biopsy to stage HCV disease prior to consideration of anti-HCV therapy. A total of 92 HIV-HCV coinfected and 372 HCV monoinfected patients were included. As might be expected, coinfected patients differed from monoinfected patients in a number of ways, including having lower body mass index (BMI), and lower alcohol intake. Liver disease was very similar between the two groups, with mean fibrosis score of 1.45 u for coinfected and 1.53 u for monoinfected (p = NS). Histological inflammation score dominated multivariate models of fibrosis when it was included in them. When only clinical predictors were used in multivariate models, BMI and type 2 diabetes had independent associations in monoinfected patients, whereas low CD4 count, current or nadir, was the only variable with an independent association in coinfected patients. Coinfected patients do not have uniformly worse liver disease than monoinfected patients. Immune compromise plays an important role in liver disease in coinfected patients, and the role of other clinical factors in liver disease may differ between these two groups, as well.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9270
1572-0241
DOI:10.1111/j.1572-0241.2006.00613.x